Leading medical specialists will gather with mesothelioma patients, families, friends and advocates at the much-anticipated 2022 International Symposium on Malignant Mesothelioma, July 23, in…
Patients with malignant pleural mesothelioma may be turning to orally inhalable gene therapy in the future, easing the treatment burden for this cancer with…
Utilizing recent public feedback, the U.S. Environmental Protection Agency finalized its strategy and goals for the much-anticipated Risk Evaluation for Asbestos Part 2. Its…
Princess Margaret Cancer Centre in Toronto recently opened a first-of-its-kind clinical trial that hopes to build on earlier pioneering efforts to turn…
Importation of raw chrysotile asbestos into the United States increased dramatically earlier this year, despite the growing movement toward tighter regulation and a potential…
Over the years, I have “collected” many families affected by the BAP1 cancer syndrome, a novel medical condition we discovered in 2011. Pathogenic germline…
Dr. Michele Carbone is a world-renowned authority on genetic mutations and the development of mesothelioma cancer.
Fact-checked and verified content:
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
